SK283079B6 - Použitie ekdysteroidov alebo ekdysteroidových derivátov na prípravu kozmetickej alebo dermatologickej kompozície - Google Patents

Použitie ekdysteroidov alebo ekdysteroidových derivátov na prípravu kozmetickej alebo dermatologickej kompozície Download PDF

Info

Publication number: SK283079B6
Authority: SK; Slovakia
Prior art keywords: ecdysteroid; skin; use according; derivative; ecdysterone
Prior art date: 1992-08-25

Application number

SK250-95A

Other languages

English (en)

Slovak (sk)

Other versions

SK25095A3 (en

Inventor

Alain Meybeck

Fr�D�Ric Bonte

G�Rard Redziniak

Original Assignee

Lvmh Recherche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-25

Filing date

1993-08-20

Publication date

2003-02-04

1993-08-20 Application filed by Lvmh Recherche filed Critical Lvmh Recherche

1995-09-13 Publication of SK25095A3 publication Critical patent/SK25095A3/sk

2003-02-04 Publication of SK283079B6 publication Critical patent/SK283079B6/sk

Links

150000002061 ecdysteroids Chemical class 0.000 title claims abstract description 90
239000002537 cosmetic Substances 0.000 title claims abstract description 29
239000000203 mixture Substances 0.000 claims abstract description 58
210000003491 skin Anatomy 0.000 claims abstract description 56
239000000284 extract Substances 0.000 claims abstract description 40
210000002510 keratinocyte Anatomy 0.000 claims abstract description 36
241001465754 Metazoa Species 0.000 claims abstract description 23
239000001963 growth medium Substances 0.000 claims abstract description 18
230000004888 barrier function Effects 0.000 claims abstract description 15
210000004027 cell Anatomy 0.000 claims abstract description 11
239000006143 cell culture medium Substances 0.000 claims abstract description 4
NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 claims description 37
HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 claims description 35
DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 claims description 35
NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 claims description 35
239000000126 substance Substances 0.000 claims description 35
241000196324 Embryophyta Species 0.000 claims description 29
238000002360 preparation method Methods 0.000 claims description 26
230000004069 differentiation Effects 0.000 claims description 22
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
239000002502 liposome Substances 0.000 claims description 21
210000004927 skin cell Anatomy 0.000 claims description 18
240000000031 Achyranthes bidentata Species 0.000 claims description 11
229920000858 Cyclodextrin Polymers 0.000 claims description 11
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 11
241001426527 Rhaponticum Species 0.000 claims description 9
230000002708 enhancing effect Effects 0.000 claims description 8
206010013786 Dry skin Diseases 0.000 claims description 7
241000219289 Silene Species 0.000 claims description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
230000037336 dry skin Effects 0.000 claims description 7
230000009993 protective function Effects 0.000 claims description 7
230000001185 psoriatic effect Effects 0.000 claims description 7
229910052918 calcium silicate Inorganic materials 0.000 claims description 6
230000000887 hydrating effect Effects 0.000 claims description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
241000410338 Ajuga decumbens Species 0.000 claims description 5
241000592274 Polypodium vulgare Species 0.000 claims description 5
229920002674 hyaluronan Polymers 0.000 claims description 5
229960003160 hyaluronic acid Drugs 0.000 claims description 5
239000000419 plant extract Substances 0.000 claims description 5
208000017520 skin disease Diseases 0.000 claims description 5
LQGNCUXDDPRDJH-UHFFFAOYSA-N 3'-GMP Natural products C1C(O)C(O)CC2(C)C(C(O)CC3(C(C(C)(O)C(O)CCC(C)C)CCC33O)C)C3=CC(=O)C21 LQGNCUXDDPRDJH-UHFFFAOYSA-N 0.000 claims description 4
241000063328 Cyanotis arachnoidea Species 0.000 claims description 4
RVMAVGROMRTERF-UHFFFAOYSA-N ajugasterone C Natural products CC(C)CCC(O)C(C)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3C(O)CC12C RVMAVGROMRTERF-UHFFFAOYSA-N 0.000 claims description 4
LQGNCUXDDPRDJH-CNDNGNGWSA-N ajugasterone C Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)C([C@H](O)C[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 LQGNCUXDDPRDJH-CNDNGNGWSA-N 0.000 claims description 4
230000003648 hair appearance Effects 0.000 claims description 4
238000005728 strengthening Methods 0.000 claims description 4
239000003104 tissue culture media Substances 0.000 claims description 4
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
JNTQSSGVHLUIBL-UHFFFAOYSA-N 2-Desoxyecdysteron Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 JNTQSSGVHLUIBL-UHFFFAOYSA-N 0.000 claims description 3
240000005748 Achyranthes aspera Species 0.000 claims description 3
235000005517 Achyranthes aspera Nutrition 0.000 claims description 3
241000241550 Cyathula Species 0.000 claims description 3
241001078460 Klasea sogdiana Species 0.000 claims description 3
241001426390 Rhaponticum integrifolium Species 0.000 claims description 3
VJMAITQRABEEKP-UHFFFAOYSA-N [6-(phenylmethoxymethyl)-1,4-dioxan-2-yl]methyl acetate Chemical compound O1C(COC(=O)C)COCC1COCC1=CC=CC=C1 VJMAITQRABEEKP-UHFFFAOYSA-N 0.000 claims description 3
239000013543 active substance Substances 0.000 claims description 3
241001645425 Ajuga iva Species 0.000 claims description 2
241000255789 Bombyx mori Species 0.000 claims description 2
241001249699 Capitata Species 0.000 claims description 2
241000514824 Cyathula officinalis Species 0.000 claims description 2
241000156647 Daiswa dunniana Species 0.000 claims description 2
241000244987 Daiswa polyphylla Species 0.000 claims description 2
241000759815 Hebanthe paniculata Species 0.000 claims description 2
241000243560 Paris axialis Species 0.000 claims description 2
241000156644 Paris vietnamensis Species 0.000 claims description 2
241000918798 Serratula tinctoria Species 0.000 claims description 2
240000003057 Sesuvium portulacastrum Species 0.000 claims description 2
235000015999 Sesuvium portulacastrum Nutrition 0.000 claims description 2
240000006271 Vitex glabrata Species 0.000 claims description 2
230000001737 promoting effect Effects 0.000 claims description 2
241001306755 Leuzea Species 0.000 claims 1
101150034459 Parpbp gene Proteins 0.000 claims 1
241000759899 Pfaffia iresinoides Species 0.000 claims 1
241000142810 Silene flos-cuculi Species 0.000 claims 1
239000002609 medium Substances 0.000 abstract description 14
210000004209 hair Anatomy 0.000 abstract description 2
210000002615 epidermis Anatomy 0.000 abstract 1
230000003014 reinforcing effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 description 30
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
239000000243 solution Substances 0.000 description 17
230000008569 process Effects 0.000 description 14
239000006071 cream Substances 0.000 description 13
150000002632 lipids Chemical class 0.000 description 12
239000000839 emulsion Substances 0.000 description 9
239000003981 vehicle Substances 0.000 description 9
241000238631 Hexapoda Species 0.000 description 8
238000000605 extraction Methods 0.000 description 8
239000000047 product Substances 0.000 description 7
239000013589 supplement Substances 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
230000000694 effects Effects 0.000 description 6
239000000499 gel Substances 0.000 description 6
208000035475 disorder Diseases 0.000 description 5
238000003756 stirring Methods 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 4
201000004681 Psoriasis Diseases 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
229920002125 Sokalan® Polymers 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000012876 carrier material Substances 0.000 description 4
239000008187 granular material Substances 0.000 description 4
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
238000010348 incorporation Methods 0.000 description 4
239000002904 solvent Substances 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
102000009024 Epidermal Growth Factor Human genes 0.000 description 3
108010076876 Keratins Proteins 0.000 description 3
102000011782 Keratins Human genes 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
239000008135 aqueous vehicle Substances 0.000 description 3
229940076810 beta sitosterol Drugs 0.000 description 3
LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
210000000736 corneocyte Anatomy 0.000 description 3
230000003752 improving hair Effects 0.000 description 3
210000003963 intermediate filament Anatomy 0.000 description 3
239000008267 milk Substances 0.000 description 3
235000013336 milk Nutrition 0.000 description 3
210000004080 milk Anatomy 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
230000010412 perfusion Effects 0.000 description 3
239000008194 pharmaceutical composition Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000000523 sample Substances 0.000 description 3
229950005143 sitosterol Drugs 0.000 description 3
JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
239000002028 Biomass Substances 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
206010040844 Skin exfoliation Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
230000001133 acceleration Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 2
239000000287 crude extract Substances 0.000 description 2
229940000033 dermatological agent Drugs 0.000 description 2
239000003241 dermatological agent Substances 0.000 description 2
210000001047 desmosome Anatomy 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
210000000301 hemidesmosome Anatomy 0.000 description 2
239000012510 hollow fiber Substances 0.000 description 2
238000000265 homogenisation Methods 0.000 description 2
229960000890 hydrocortisone Drugs 0.000 description 2
230000006872 improvement Effects 0.000 description 2
229940039009 isoproterenol Drugs 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000004005 microsphere Substances 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
239000003921 oil Substances 0.000 description 2
210000003463 organelle Anatomy 0.000 description 2
230000035515 penetration Effects 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
210000004761 scalp Anatomy 0.000 description 2
238000000926 separation method Methods 0.000 description 2
KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
230000036555 skin type Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
-1 soybean lecithin Chemical class 0.000 description 2
241000894007 species Species 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
241001519271 Ajuga Species 0.000 description 1
241000255791 Bombyx Species 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
241000426256 Cyanotis Species 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
241001596797 Eurypegasus draconis Species 0.000 description 1
241000161991 Fargesia Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
241000133174 Serratula Species 0.000 description 1
241000912003 Serratula inermis Species 0.000 description 1
241000201979 Sesuvium Species 0.000 description 1
241000142805 Silene otites Species 0.000 description 1
241001535115 Silene tatarica Species 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
229940087168 alpha tocopherol Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000012223 aqueous fraction Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
238000000889 atomisation Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
239000002021 butanolic extract Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000010267 cellular communication Effects 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000013068 control sample Substances 0.000 description 1
239000008278 cosmetic cream Substances 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000035617 depilation Effects 0.000 description 1
230000035618 desquamation Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
235000019800 disodium phosphate Nutrition 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
YAIZECBIJHIPCU-UHFFFAOYSA-N ecdysterone 22-acetate Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(CCC(C)(C)O)OC(=O)C)CCC33O)C)C3=CC(=O)C21 YAIZECBIJHIPCU-UHFFFAOYSA-N 0.000 description 1
210000001339 epidermal cell Anatomy 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
239000003822 epoxy resin Substances 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
210000003780 hair follicle Anatomy 0.000 description 1
230000036541 health Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
206010021198 ichthyosis Diseases 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000003780 keratinization Effects 0.000 description 1
108010075526 keratohyalin Proteins 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
230000003902 lesion Effects 0.000 description 1
239000008297 liquid dosage form Substances 0.000 description 1
230000036244 malformation Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
235000019796 monopotassium phosphate Nutrition 0.000 description 1
BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
238000010606 normalization Methods 0.000 description 1
239000007764 o/w emulsion Substances 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
239000002245 particle Substances 0.000 description 1
PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
229920000647 polyepoxide Polymers 0.000 description 1
239000008389 polyethoxylated castor oil Substances 0.000 description 1
238000004321 preservation Methods 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
230000037075 skin appearance Effects 0.000 description 1
230000008591 skin barrier function Effects 0.000 description 1
230000037067 skin hydration Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229940083466 soybean lecithin Drugs 0.000 description 1
239000008347 soybean phospholipid Substances 0.000 description 1
238000010025 steaming Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000009466 transformation Effects 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9741—Pteridophyta [ferns]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Mycology (AREA)
Botany (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Cosmetics (AREA)
Steroid Compounds (AREA)

SK250-95A 1992-08-25 1993-08-20 Použitie ekdysteroidov alebo ekdysteroidových derivátov na prípravu kozmetickej alebo dermatologickej kompozície SK283079B6 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9210267A FR2695035A1 (fr)	1992-08-25	1992-08-25	Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues.
PCT/FR1993/000819 WO1994004132A2 (fr)	1992-08-25	1993-08-20	Utilisation d'un ecdysteroid en cosmetique ou dermatologie

Publications (2)

Publication Number	Publication Date
SK25095A3 SK25095A3 (en)	1995-09-13
SK283079B6 true SK283079B6 (sk)	2003-02-04

Family

ID=9433012

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK250-95A SK283079B6 (sk)	1992-08-25	1993-08-20	Použitie ekdysteroidov alebo ekdysteroidových derivátov na prípravu kozmetickej alebo dermatologickej kompozície

Country Status (16)

Country	Link
US (1)	US5609873A (es)
AU (1)	AU4964193A (es)
BE (1)	BE1007320A5 (es)
CA (1)	CA2143295A1 (es)
CH (1)	CH685474A5 (es)
DE (2)	DE4393944B4 (es)
ES (1)	ES2110347B1 (es)
FR (2)	FR2695035A1 (es)
GB (1)	GB2286121B (es)
HU (1)	HUT71057A (es)
IT (1)	IT1261243B (es)
MC (1)	MC2339A1 (es)
MX (1)	MX9305118A (es)
RU (1)	RU2143884C1 (es)
SK (1)	SK283079B6 (es)
WO (1)	WO1994004132A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69433669T2 (de) *	1994-01-12	2005-01-05	Pola Chemical Industries, Inc.	Mittel für VERBESSERTE Durchblutung UND KOSMETISCHE MITTEL
DE19643587A1 (de) *	1996-10-22	1998-04-23	Beiersdorf Ag	Antiadhäsive Sterole und Sterolderivate
DE19751550C2 (de) *	1997-11-20	2001-03-08	Kao Corp	Verwendung einer Wirkstoffzusammensetzung in Haarpflegemitteln
FR2779052B1 (fr) *	1998-05-28	2000-08-25	Fabre Pierre Dermo Cosmetique	Compositions capillaires contenant un extrait de pfaffia paniculata
FR2779058B1 (fr) *	1998-05-29	2003-02-21	Dior Christian Parfums	Utilisation d'au moins une saponine ou un sapogenol cosmetiquement acceptable, comme agent cosmetique destine a augmenter la quantite de collagene iv dans la jonction dermo-epidermique
FR2801504B1 (fr) *	1999-11-26	2002-02-15	Lvmh Rech	Extrait d'ajuga turkestanica et ses applications cosmetiques
EP1145709A1 (de) *	2000-04-14	2001-10-17	Laboratoires Serobiologiques	Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
RU2246966C1 (ru) *	2003-11-04	2005-02-27	Институт нефтехимии и катализа АН РБ и УНЦ РАН	СПОСОБ ПОЛУЧЕНИЯ α-ЭКДИЗОНА
US20050106258A1 (en) *	2003-11-17	2005-05-19	Jiao Gong	Pharmacology and manufacturing method of Bombyx moriL related bioproduct
FR2863878B1 (fr) *	2003-12-22	2006-06-30	Oreal	Utilisation d'ecdysteroides pour la preparation de compositions dermathologiques ou cosmetiques anti-chute de cheveux.
FR2863886B1 (fr) *	2003-12-22	2007-05-04	Oreal	Utilisation d'un ligand steroidien ou non-steroidien du recepteur ecr dans une preparation cosmetique ou dermatologique pour maintenir l'homeostasie cutanee.
FR2876032B1 (fr) *	2004-10-05	2008-10-31	Greentech Sa Sa	Utilisation d'extraits de fougeres dans des preparations cosmetiques ou dermatologiques
US20050191385A1 (en) *	2004-10-25	2005-09-01	Amato Daniel K.	Natural product derivatives as food supplements and pharmaceuticals
US20070059269A1 (en) *	2005-08-17	2007-03-15	L'oreal	Administration of 8-hexadecene-1,16-dicarboxylic acid for promoting cohesion of the epidermal horny layer
FR2893846B1 (fr) *	2005-11-25	2010-07-30	Am Phyto Conseil	Utilisation d'un ecdysteroide pour reparer les dommages causes aux cellules cutanees par l'exposition aux rayonnements ultraviolets
FR2933869B1 (fr) *	2008-07-16	2012-04-06	Am Phyto Conseil	Utilisation d'un extrait aqueux ou organique ou hydro-organique de microsorum
FR2945213B1 (fr) *	2009-05-07	2015-10-16	Rocher Yves Biolog Vegetale	Compositions cosmetiques et dermatologiques et dermatologiques a base d'extrait de silene.
CN101919887B (zh) *	2010-07-16	2012-05-23	宜昌市伍家岗区怡康皮肤病研究所	一种治疗银屑病的药物及其制备方法
ES2397890B1 (es)	2011-03-25	2014-02-07	Lipotec, S.A.	Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
EP2752183B1 (de)	2013-01-07	2015-04-22	Golüke, Timm	Kosmetikum mit biologischem Naturstoffkomplex
RU2572334C2 (ru) *	2013-12-06	2016-01-10	Общество С Ограниченной Ответственностью "Луфатен"	Клатратный комплекс арабиногалактана или гуммиарабика с 20-гидроксиэкдизоном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
CN103788162B (zh) *	2014-01-07	2016-01-13	青岛农业大学	一种从菠菜中提取蜕皮激素的方法
CN105440095A (zh) *	2014-08-28	2016-03-30	江苏柯菲平医药股份有限公司	一种富含β-蜕皮甾酮的露水草提取纯化方法
CN104844676B (zh) *	2015-04-17	2017-12-29	浙江惠松制药有限公司	一种从菠菜中提取蜕皮激素的方法
WO2020131058A1 (en) *	2018-12-20	2020-06-25	Muhammed Majeed	Telomerase enhancement potential of ecdysterone
DE102021124078A1 (de) *	2021-09-17	2023-03-23	Timm Golüke	Kosmetikzusammensetzung zur Anwendung auf der Haut
CN116869901A (zh) *	2023-08-25	2023-10-13	欧诗漫生物股份有限公司	一种重楼提取物在抑制黑色素转移中的应用以及化妆品

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH478565A (it) *	1963-06-19	1969-09-30	Hunger Ricci Gabriella	Procedimento per ottenere estratti oleosi ormonali impiegabili in cosmesi da ninfe e crisalidi di insetti
FR1494371A (fr) *	1965-08-13	1967-09-08	Hoffmann La Roche	Procédé pour la préparation de 5beta-eta-6-céto-stéroïdes
US3378549A (en) *	1965-11-04	1968-04-16	Syntex Corp	2, 3-acetonides of polyhydroxy bis norchol-7-enoic acid derivatives
US3354154A (en) *	1966-01-26	1967-11-21	Syntex Corp	2beta, 3beta-alkylidenedioxy-6-hydroxy-22, 23-bisnorchol-7-enoic acid alkyl esters and process for the production thereof
US3354152A (en) *	1966-01-26	1967-11-21	Syntex Corp	2beta, 3beta-alkylidenedioxy-6-oxygenated-delta-steroids and process for the preparation thereof
US3455905A (en) *	1966-05-26	1969-07-15	Zoecon Corp	Polyhydroxy steroids and processes for their preparation
FR1524924A (fr) *	1966-05-31	1968-05-10	Syntex Corp	Procédé de préparation de céto-6 hydroxy-14 alpha-déhydro- delta 7 stéroïdes
US3440241A (en) *	1966-05-31	1969-04-22	Syntex Corp	Preparation of 6-keto-14alpha-hydroxy-delta**7-dehydro steroids
FR1525385A (fr) *	1966-10-19	1968-05-17	Rohto Pharma	Nouveau procédé de production d'inocostérone et d'iso-inocostérone à partir de végétaux
US3527777A (en) *	1968-03-05	1970-09-08	Ceskoslovenska Akademie Ved	Method for obtaining ecdysterones
IL38540A0 (en) *	1971-01-18	1972-03-28	Dauten Sa	Method for the extraction of insect moulting steroid hormones
IT1118225B (it) *	1977-08-12	1986-02-24	Simes	Procedimento per l'ottenimento di steroidi poliossidrilati,lisergolo ed alcaloidi ergolici
SU924051A1 (ru) *	1978-10-10	1982-04-30	Inst Khim Rastitelnykh Veshche	Способ получения экдистерона
FR2521565B1 (fr) *	1982-02-17	1985-07-05	Dior Sa Parfums Christian	Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
JPS5910600A (ja) *	1982-07-09	1984-01-20	Wakunaga Seiyaku Kk	β−エクジソンの製造法
FR2534487B1 (fr) *	1982-10-15	1988-06-10	Dior Christian Parfums	Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede
SU1130605A1 (ru) *	1982-11-04	1984-12-23	Институт биологии развития им.Н.К.Кольцова	Способ определени экдистерона в культуральной среде
SU1146050A1 (ru) *	1983-04-13	1985-03-23	Институт биохимии им.А.В.Палладина	Способ получени @ -экдизона из растени рода @
SU1326271A1 (ru) *	1984-06-04	1987-07-30	Специализированное Конструкторское Бюро Химизации	Крем дл кожи лица
JPS632928A (ja) *	1986-06-20	1988-01-07	Japan Bio Kenkyusho:Kk	鎮痛剤
CN86106791A (zh) *	1986-09-30	1988-04-13	中国科学院昆明植物研究所	护肤化妆品
FR2637182B1 (fr) *	1988-10-03	1992-11-06	Lvmh Rech	Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant
FR2645741B1 (fr) *	1989-03-20	1995-06-23	Dior Christian Parfums	Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
RU2028139C1 (ru) *	1992-07-08	1995-02-09	Светлана Ивановна Колинько	Гель "шелковый" для ухода за кожей лица
RU2036640C1 (ru) *	1993-05-12	1995-06-09	Фармацевтическое научно-производственное предприятие "Ретиноиды"	Мазь для лечения заболеваний с нарушением керотинизации и целостности кожи

1992
- 1992-08-25 FR FR9210267A patent/FR2695035A1/fr active Pending
1993
- 1993-08-20 RU RU95106600A patent/RU2143884C1/ru not_active IP Right Cessation
- 1993-08-20 HU HU9500446A patent/HUT71057A/hu unknown
- 1993-08-20 BE BE9300855A patent/BE1007320A5/fr not_active IP Right Cessation
- 1993-08-20 ES ES09450012A patent/ES2110347B1/es not_active Expired - Fee Related
- 1993-08-20 AU AU49641/93A patent/AU4964193A/en not_active Abandoned
- 1993-08-20 CH CH1289/94A patent/CH685474A5/fr not_active IP Right Cessation
- 1993-08-20 DE DE4393944A patent/DE4393944B4/de not_active Expired - Fee Related
- 1993-08-20 CA CA002143295A patent/CA2143295A1/en not_active Abandoned
- 1993-08-20 WO PCT/FR1993/000819 patent/WO1994004132A2/fr not_active Ceased
- 1993-08-20 US US08/393,009 patent/US5609873A/en not_active Expired - Lifetime
- 1993-08-20 SK SK250-95A patent/SK283079B6/sk not_active IP Right Cessation
- 1993-08-20 GB GB9503272A patent/GB2286121B/en not_active Expired - Fee Related
- 1993-08-20 FR FR9310138A patent/FR2696075B1/fr not_active Expired - Fee Related
- 1993-08-20 DE DE4393944T patent/DE4393944T1/de active Pending
- 1993-08-20 MC MC2251A patent/MC2339A1/fr unknown
- 1993-08-20 IT ITTO930626A patent/IT1261243B/it active IP Right Grant
- 1993-08-24 MX MX9305118A patent/MX9305118A/es unknown

Also Published As

Publication number	Publication date
MC2339A1 (fr)	1994-09-28
IT1261243B (it)	1996-05-09
ES2110347B1 (es)	1998-10-01
HU9500446D0 (en)	1995-04-28
HUT71057A (en)	1995-11-28
ES2110347A1 (es)	1998-02-01
FR2696075B1 (fr)	1995-10-13
US5609873A (en)	1997-03-11
GB9503272D0 (en)	1995-04-12
DE4393944B4 (de)	2007-04-05
WO1994004132A2 (fr)	1994-03-03
FR2695035A1 (fr)	1994-03-04
SK25095A3 (en)	1995-09-13
BE1007320A5 (fr)	1995-05-16
GB2286121B (en)	1996-11-27
DE4393944T1 (de)	1995-10-05
CH685474A5 (fr)	1995-07-31
ITTO930626A1 (it)	1995-02-20
MX9305118A (es)	1994-05-31
AU4964193A (en)	1994-03-15
WO1994004132A3 (fr)	1994-08-04
RU95106600A (ru)	1997-02-27
RU2143884C1 (ru)	2000-01-10
ITTO930626A0 (it)	1993-08-20
CA2143295A1 (en)	1994-03-03
FR2696075A1 (fr)	1994-04-01
GB2286121A (en)	1995-08-09

Publication	Publication Date	Title
SK283079B6 (sk)	2003-02-04	Použitie ekdysteroidov alebo ekdysteroidových derivátov na prípravu kozmetickej alebo dermatologickej kompozície
US5198225A (en)	1993-03-30	Hydrated lipidic lamellar phases or liposomes based on ecdysteroids
DE60030766T2 (de)	2007-09-06	Verwendung eines extraktes der gattung vaccinium als anti-glykations-agens
US5607693A (en)	1997-03-04	Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss
US5723149A (en)	1998-03-03	Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
DE60036169T2 (de)	2008-05-21	Methoden zur Behandlung der Hautpigmentierung
DE69108256T2 (de)	1995-11-02	Anwendug der saponine von medicago für die herstellung von kosmetischen oder pharmazeutischen namentlich dermatologischen zusammensetzungen welche die erneuerung der epidermis fördern,das wiederwachstum der haare stimulieren oder ihren ausfall verzögern.
DE69925928T2 (de)	2006-08-17	Verwendung einer sich an periphere benzodiazepinrezeptoren bindenden substanz zur behandlung von hautstress
US5514374A (en)	1996-05-07	Cosmetic or pharmaceutical composition containing a black horehound extract
EP0993822A1 (en)	2000-04-19	Ceramide production-accelerating agent
US5891464A (en)	1999-04-06	Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it
US5653983A (en)	1997-08-05	Compositions for the pigmentation of the skin or of the hair containing an extract of Marrubium vulgare, the process for it's manufacture and it's
US4670255A (en)	1987-06-02	Hair tonic composition
DE69803200T2 (de)	2002-10-31	Verwendung mindestens eines Extrakts einer Pflanze der Gattung Chrysanthemum zur Förderung der Pigmentierung der Haut und/ oder der Haare
DE69621243T2 (de)	2002-08-29	Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
US5676948A (en)	1997-10-14	Use of a simarouba extract for reducing patchy skin pigmentation
US5624673A (en)	1997-04-29	Cosmetic or pharmaceutical composition containing a prunella extract
DE68916197T2 (de)	1994-09-29	Zusammensetzung zur in-vivo bzw. in-vitro steigerung des melaningehaltes der melanocyten und deren in-vitro verwendung.
JP2005179367A (ja)	2005-07-07	毛髪の喪失を阻止する皮膚科学的又は化粧品組成物の製造のためのエクディステロイドの使用
KR20200014570A (ko)	2020-02-11	피부 생기 부여 및 활력 증대를 위한 윙스템패션플라워 캘러스 배양물 또는 그 추출물을 함유하는 피부개선용 화장료 조성물
US5202126A (en)	1993-04-13	Composition containing pregnenolone or a pregnenolone ester incorporated in liposomes, and a method for regenerating, or revitalizing the skin therewith
US5676949A (en)	1997-10-14	Use of a simaba extract to reduce patchy skin pigmentation, enhance the protective function of the skin or prepare a skin cell culture medium and resulting composition
KR20050017497A (ko)	2005-02-22	헛개나무 열매 추출물을 함유하는 피부 노화 방지효과를갖는 화장료 조성물 및 그 제조 방법
Carlisle et al.	1979	Aging model for unexposed human dermis
CH710438B1 (de)	2016-06-15	Kosmetische Zusammensetzung zur Behandlung von Follikelinseln der Kopfhaut.

Legal Events

Date	Code	Title	Description
2013-05-03	MM4A	Patent lapsed due to non-payment of maintenance fees	Effective date: 20120820